// App-Quantinova.ai

3014 : Pharmacokinetics of the CDC7 inhibitor LY3143921 hydrate, a CRUK first-in-human phase I trial in patients with advanced solid tumors

Researchers

Presenter

  • Shelby Barnett

Principal Investigators

  • Melanie Griffin

  • Richard H. Wilson

  • Elizabeth R. Plummer

  • Jeffry T. Evans

  • Victoria Coyle

  • Sally Clive

  • Lisa Godfrey

  • Nicola Dobbs

  • Lesley McGuigan

  • Sue Brook

  • Gavin Halbert

  • Gareth J. Veal

Medical Centers

  • Newcastle University, Newcastle upon Tyne, United Kingdom

  • University of Glasgow, Glasgow, United Kingdom

  • Queen's University Belfast, Belfast, United Kingdom

  • Western General Hospital, Edinburgh, United Kingdom

  • Cancer Research UK, Southampton, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • LY3143921

Outcome

  • N/A

Study Design

  • Pharmacokinetics

  • First-In-Human

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved